Psychiatry & Behavioral Health

Alcohol Use Disorder

Alcohol Use Disorder (AUD) is a chronic medical condition that affects millions of individuals and families across the United States. CenExel supports innovative clinical research focused on improving treatment outcomes, reducing relapse risk, and advancing evidence-based therapies for adults living with alcohol dependence and co-occurring behavioral health conditions.

Studies Conducted
0 +
Trial Participants
0 +
Active Sites
0 +
Overview

Advancing Alcohol Use Disorder Clinical Research

CenExel delivers specialized scientific and operational expertise for Alcohol Use Disorder clinical trials. Our experienced behavioral health research teams support sponsors with patient recruitment, treatment evaluation, biomarker strategies, and regulatory-focused execution from early phase through post-market studies.

Optimize Patient Retention

Experienced site teams and patient-focused engagement strategies help improve participant compliance and long-term retention.

Accelerate Study Outcomes

Integrated operational workflows and experienced investigators support faster enrollment and efficient study execution.
Conditions Covered

Alcohol Use Disorder Research Areas

CenExel supports a broad range of Alcohol Use Disorder and addiction-related clinical research programs.

  • Alcohol Dependence
  • Alcohol Withdrawal Syndrome
  • Relapse Prevention
  • Craving Reduction
  • Co-Occurring Anxiety Disorders
  • Depression & AUD
  • Substance Use Disorders
  • Dual Diagnosis Conditions
Our Approach

Why Sponsors Choose CenExel for Alcohol Use Disorder Studies

CenExel combines deep behavioral health expertise with scalable recruitment strategies and experienced clinical operations teams to support Alcohol Use Disorder research programs nationwide.

01

Addiction Research Expertise

Dedicated behavioral health investigators with extensive experience in addiction medicine and substance use disorder trials.

02

Diverse Patient Recruitment

Access to broad patient populations across multiple regions improves enrollment diversity and study representation.

03

Biomarker & Outcome Strategiesx

Support for advanced endpoints, patient-reported outcomes, and relapse monitoring methodologies.

04

High Retention Rates

Patient engagement programs designed to reduce dropout rates and improve long-term participation.

Phase Coverage

Supported Alcohol Use Disorder Trial Phases

CenExel supports early and late phase Alcohol Use Disorder clinical trials — from first-in-human safety studies through Phase IV post-market research.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our research sites support medication-assisted treatment studies, behavioral therapy evaluations, relapse prevention programs, and neuroscience-focused addiction research initiatives.

Alcohol Use Disorder Task Force

CenExel supports clinical trials focused on alcohol dependence, addiction recovery, withdrawal management, relapse prevention, and co-occurring psychiatric disorders across adult and behavioral health populations.

Active Sites

15 Sites

CenExel Gaithersburg
CenExel Garden Grove
CenExel Atlanta
CenExel Marlton
CenExel Hollywood

Our Blog